MNOVMEDICINOVA INC
- Market cap
- $68.42M
- as of 2026-10-23
- Latest close
- $1.39
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2024-01-11
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| 3D Opportunity Master Fund | Sep 25 | Sep 29 | S | 640,000 | $2.70 | Sale −$1,728,000 | 4,862,047 | No | Form 4 |
| Beaver Carolyn | Jun 23 | Jun 25 | A · derivative | 44,500 | $1.36 | $60,520 | 44,500 | No | Form 4 |
| Lemerond Nicole | Jun 23 | Jun 25 | A · derivative | 44,500 | $1.36 | $60,520 | 44,500 | No | Form 4 |
| Nagao Hideki | Jun 23 | Jun 25 | A · derivative | 44,500 | $1.36 | $60,520 | 44,500 | No | Form 4 |
| Iwaki YuichiPresident and CEO | Jan 16 | Jan 20 | A · derivative | 450,000 | $2.10 | $945,000 | 450,000 | No | Form 4 |
| Matsuda KazukoChief Medical Officer | Jan 16 | Jan 20 | A · derivative | 350,000 | $2.10 | $735,000 | 350,000 | No | Form 4 |
| Beaver Carolyn | Jun 17, 2025 | Jun 20, 2025 | A · derivative | 20,000 | $1.26 | $25,200 | 20,000 | No | Form 4 |
| Lemerond Nicole | Jun 17, 2025 | Jun 20, 2025 | A · derivative | 20,000 | $1.26 | $25,200 | 20,000 | No | Form 4 |
| Nagao Hideki | Jun 17, 2025 | Jun 20, 2025 | A · derivative | 20,000 | $1.26 | $25,200 | 20,000 | No | Form 4 |
| Beaver Carolyn | Feb 12, 2025 | Feb 14, 2025 | A · derivative | 24,500 | $1.84 | $45,080 | 24,500 | No | Form 4 |
| Iwaki YuichiPresident and CEO | Feb 12, 2025 | Feb 14, 2025 | A · derivative | 100,000 | $1.84 | $184,000 | 100,000 | No | Form 4 |
| Lemerond Nicole | Feb 12, 2025 | Feb 14, 2025 | A · derivative | 24,500 | $1.84 | $45,080 | 24,500 | No | Form 4 |
| Matsuda KazukoChief Medical Officer | Feb 12, 2025 | Feb 14, 2025 | A · derivative | 100,000 | $1.84 | $184,000 | 100,000 | No | Form 4 |
| Nagao Hideki | Feb 12, 2025 | Feb 14, 2025 | A · derivative | 24,500 | $1.84 | $45,080 | 24,500 | No | Form 4 |
| Matsuda KazukoChief Medical Officer | Jan 7, 2025 | Jan 10, 2025 | A · derivative | 300,000 | $1.52 | $456,000 | 300,000 | No | Form 4 |
| Iwaki YuichiPresident and CEO | Jan 7, 2025 | Jan 10, 2025 | A · derivative | 400,000 | $1.52 | $608,000 | 400,000 | No | Form 4 |
| Beaver Carolyn | Jun 11, 2024 | Jun 12, 2024 | A · derivative | 20,000 | $1.34 | $26,800 | 20,000 | No | Form 4 |
| Lemerond Nicole | Jun 11, 2024 | Jun 12, 2024 | A · derivative | 20,000 | $1.34 | $26,800 | 20,000 | No | Form 4 |
| Nagao Hideki | Jun 11, 2024 | Jun 12, 2024 | A · derivative | 20,000 | $1.34 | $26,800 | 20,000 | No | Form 4 |
| Iwaki YuichiPresident and CEO | Jan 9, 2024 | Jan 11, 2024 | A · derivative | 210,000 | $2.40 | $504,000 | 210,000 | No | Form 4 |
| Matsuda KazukoChief Medical Officer | Jan 9, 2024 | Jan 11, 2024 | A · derivative | 157,500 | $2.40 | $378,000 | 157,500 | No | Form 4 |
| OBrien GeoffreyVice President | Jan 9, 2024 | Jan 11, 2024 | A · derivative | 84,000 | $2.40 | $201,600 | 84,000 | No | Form 4 |